Miltenyi Biotec’s Immuno-Oncology Innovation Award honors researchers around the globe for their contributions to thei immuno-oncology field. Innovative research will be awrded with travel, accommodation, and registration fees for the AACR Annual Meeting 2019.
Submit your abstract before February 14, 2019.
Submit your abstract here.
*Check out our website for additional meetings covered by the Immuno-Oncology Innovation Award. Miltenyi Biotec will be giving away one Immuno-Oncology Innovation Award to one winner for each meeting.
American Association for Cancer Research (AACR) Annual Meeting
March 30–April 03, 2019 | Atlanta, Georgia, USA
Abstract submission deadline: February 14, 2019
Travel award winner announcement: March 01, 2019
The 18th Meeting of the Society for Natural Immunity
September 30–October 03, 2019 | Luxembourg
Abstract submission deadline: August 16, 2019
Travel award winner announcement: September 01, 2019
*This contest is open for participation, at no charge, according to the respective deadlines.
To give research teams extra time to prepare their applications, PCORI has posted preannouncements for upcoming research funding opportunities that will open on Thursday, Jan. 3. PCORI seeks proposals for improving treatment of posttraumatic stress disorder in adults, of age-related hearing loss and of anxiety in children, adolescents and young adults. The deadline for submitting Letters of Intent for these opportunities is Thursday, Jan. 31.
Read about each Topic here.
Treatment of Post-traumatic Stress disorder in Adults — Cycle 1 2019
Treatment Options for Age-Related Hearing Loss — Cycle 1 2019
Treatment of Anxiety in children, Adolescents, and/or Young Adults — Cycle 1 2019
Broad PCORI Funding Announcements — Cycle 1 2019 (for Addressing disparities, Assessment of Options, Communication and Dissemination Research, Improving Healthcare Systems)
Letters of Intent will be due January 31, 2019 and Applications will be due April 24, 2019.
Limited funding opportunity, one applicant per institution.
Award amount: up to $100,000 for a two-year period
Internal Deadline: January 3rd, 2019, Please notify your SPAdmin contact of your intent to apply as soon as possible.
The Mary Kay Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research in ovarian, uterine, breast, or cervical cancer.
The program will offer between ten to fifteen grants. The awards will be up to $100,000 each (combined direct and indirect. Indirect costs cannot exceed 15%.) That may be used in a one year period or up to two years. Applications must be submitted by one Principal Investigator, selected by the Institution. Only one grant application will be accepted from each invited cancer research institute or medical school. Grants are limited to the United States.
The Principal Investigator that completes the applications must be Asst., Assoc., or Full time professor and the same person who signs the electronic signature. Names must match exactly. Postdoctoral trainees and instructors are NOT eligible.
Announcement of the grant awards will be made on or about May 1, 2019. A letter will be sent to the Principal Investigator following review of the applications.
Applications should include:
- Cover page
- Current Financial Support (2 pages max)
- NIH Biosketch or Equivalent, (5 pages max, all in one attachment)
- Grant application (5 pages)
- References (2 pages max)
- Letters of collaboration (3 pages max)
Proposals will be reviewed by a UNMC review committee which will select the applicant to move forward. The final proposal must submitted to the sponsor by 5 PM CST, Friday, February 8, 2019.